Literature DB >> 7013095

Studies on the chemotherapy of human opisthorchiasis in Thailand: I. Clinical trial of praziquantel.

D Bunnag, T Harinasuta.   

Abstract

Praziquantel (Embay 8440) was found to be effective in eliminating egg of Opishtorchis viverrini. from the stools of 49 patients. Two regimens were used: Group I patients received 25 mg/kg body weight three times daily after meals for two consecutive days: and Group II patients received 25 mg/kg body weight three times daily after meals for one day. In both groups eggs were not detected in the faeces by day 60 and up to 4-8 months post treatment. Mild transient side effects were present in approximately 80% of patients of Group I, with milder side effects reported in Group II. Severe diarrhoea was present on day 0 in one patient from each group. Side reactions included headache, dizziness, myalgia and lassitude, however, no laboratory evidence of toxicity was detected.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7013095

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  8 in total

1.  Update on Hepatobiliary and Pulmonary Flukes.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.725

Review 2.  Antiparasitic therapy.

Authors:  Shanthi Kappagoda; Upinder Singh; Brian G Blackburn
Journal:  Mayo Clin Proc       Date:  2011-06       Impact factor: 7.616

3.  A characteristic immunoblotting pattern for Opisthorchiasis sera with metacercarial antigens.

Authors:  S Tanvanich; G Doungchawee; S Boonpucknavig; W Thamavit
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

4.  Metabolic Profiling of Praziquantel-mediated Prevention of Opisthorchis viverrini-induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma.

Authors:  Pattama Prommajun; Jutarop Phetcharaburanin; Nisana Namwat; Poramate Klanrit; Prakasit Sa-Ngiamwibool; Malinee Thanee; Hasaya Dokduang; Yingpinyapat Kittirat; Jia V Li; Watcharin Loilome
Journal:  Cancer Genomics Proteomics       Date:  2021 Jan-Feb       Impact factor: 4.069

5.  Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose-comparison trial.

Authors:  Leonore Lovis; Tippi K Mak; Khampheng Phongluxa; Phonepasong Ayé Soukhathammavong; Youthanavanh Vonghachack; Jennifer Keiser; Penelope Vounatsou; Marcel Tanner; Christoph Hatz; Jürg Utzinger; Peter Odermatt; Kongsap Akkhavong
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24

6.  Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study.

Authors:  Supot Kamsa-Ard; Vor Luvira; Ake Pugkhem; Varisara Luvira; Bandit Thinkhamrop; Krittika Suwanrungruang; Vajarabhongsa Bhudhisawasdi
Journal:  BMC Cancer       Date:  2015-10-24       Impact factor: 4.430

7.  Modulation of dihydroxy-di-n-propylnitrosamine-induced liver lesion development in Opisthorchis-infected Syrian hamsters by praziquantel treatment in association with butylated hydroxyanisole or dehydroepiandrosterone administration.

Authors:  M A Moore; W Thamavit; D Tiwawech; N Ito; H Tsuda
Journal:  Jpn J Cancer Res       Date:  1998-11

8.  Time-dependent modulation of liver lesion development in Opisthorchis-infected Syrian hamster by an antihelminthic drug, praziquantel.

Authors:  W Thamavit; M A Moore; S Sirisinha; T Shirai; N Ito
Journal:  Jpn J Cancer Res       Date:  1993-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.